Results 71 to 80 of about 88,379 (263)

Multidrug-Resistance and Biofilm Formation among Acinetobacter baumannii Isolated from Clinical Specimens

open access: yesJournal of Nepal Health Research Council
Background: Acinetobacter baumannii has emerged as a problematic pathogen due to its ability to become resistant to antibiotics and form biofilms.
Poonam Yadav   +7 more
doaj   +1 more source

Multidrug-resistant Acinetobacter baumannii clones persist on hospital inanimate surfaces

open access: yesBrazilian Journal of Infectious Diseases, 2018
Acinetobacter baumannii is one of the most frequent Gram-negative opportunistic pathogens associated with hospital-acquired infection worldwide. We briefly describe A.
Igor Vasconcelos Rocha   +4 more
doaj   +1 more source

Rewriting Tumor Immunity With Bacterial Membrane Vesicles: A Versatile and Potent Therapeutic Strategy

open access: yesAdvanced NanoBiomed Research, EarlyView.
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi   +6 more
wiley   +1 more source

Multidrug-ResistantAcinetobacter baumannii

open access: yesEmerging Infectious Diseases, 2005
To understand the epidemiology of multidrug-resistant (MDR) Acinetobacter baumannii and define individual risk factors for multidrug resistance, we used epidemiologic methods, performed organism typing by pulsed-field gel electrophoresis (PFGE), and conducted a matched case-control retrospective study.
Aharon Abbo   +5 more
openaire   +3 more sources

Molecular epidemiological study of clinical Acinetobacter baumannii isolates: phenotype switching of antibiotic resistance [PDF]

open access: yes, 2013
BackgroundThe presence of clinical Acinetobacter baumannii (A. baumannii) isolates with differing antibiotic resistance phenotypes in the same patient causes difficulties and confusion in treatment.
Chang-Hua Chen   +2 more
core   +1 more source

Phenotypical Evaluation of Multi-Drug Resistant Acinetobacter Baumannii

open access: yesJournal of Fasa University of Medical Sciences, 2013
Background & Objective: Resistance patterns among nosocomial bacterial pathogens in hospitals may vary widely from country to country at any given point and within the same country over time.
Somayyeh Jafari   +7 more
doaj  

Molecular epidemiology of Acinetobacter baumannii during COVID-19 at a hospital in northern China

open access: yesAnnals of Clinical Microbiology and Antimicrobials
Background The wide spread of carbapenem-resistance clones of Acinetobacter baumannii has made it a global public problem. Some studies have shown that the prevalence of Acinetobacter baumannii clones can change over time.
Xinlin Huang   +9 more
doaj   +1 more source

Antimicrobial resistance patterns of Acinetobacter baumannii colonization patients skin

open access: yesمجلة كلية الطب, 2020
Background: Acinetobacter baumannii is a significant opportunistic pathogen and it is generally associated with benign colonization of hospitalized patients.
Aza Bahadeen Taha
doaj  

Untersuchung von Anti‐Glykan‐Antikörpern und Erforschung ihres medizinischen Potenzials mithilfe synthetischer Glykane

open access: yesAngewandte Chemie, EarlyView.
Anti‐Glykan‐Antikörper spielen sowohl bei Gesundheit als auch bei Krankheit eine wesentliche Rolle. Der Zugang zu neuartigen Glykanstrukturen ermöglicht Fortschritte bei der Antikörpercharakterisierung für die Entdeckung von Biomarkern, die Antikörperentwicklung und das Impfstoffdesign.
Fabienne Weber   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy